Autologous peripheral blood stem cell transplantation with high-dose therapy for anaplastic large cell lymphoma with progressive myelofibrosis / 대한내과학회지
Korean Journal of Medicine
; : 77-81, 2010.
Article
in English
| WPRIM (Western Pacific)
| ID: wpr-201326
Responsible library:
WPRO
ABSTRACT
Myelofibrosis is a myeloproliferative neoplasm characterized by abnormal bone marrow megakaryocyte proliferation with reticulin and collagen fibrosis, leukoerythroblastosis, anemia, increased level of serum lactate dehydrogenase and splenomegaly. Myelofibrosis associated with malignant lymphoma is rare and survival rates appear to have been poor. Herein, we describe our experience in a patient who remained in complete remission with high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) for ALK-negative ALCL presenting with rapidly progressing myelofibrosis.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Reticulin
/
Splenomegaly
/
Bone Marrow
/
Fibrosis
/
Megakaryocytes
/
Survival Rate
/
Collagen
/
Lymphoma, Large-Cell, Anaplastic
/
Stem Cell Transplantation
/
Peripheral Blood Stem Cell Transplantation
Limits:
Humans
Language:
English
Journal:
Korean Journal of Medicine
Year:
2010
Document type:
Article